The path to improved safety of gene-based products
Drug Discovery World
MAY 11, 2023
In addition, their cumbersome developmental process limits their use for fast-tracked new modalities, such as DNA-based vaccines. This approval could pave the way for LC-MS to transition more frequently into a good manufacturing process (GMP) environment, where it can be used as a release assay for regulatory documentation.
130 
Let's personalize your content